Evidence map›Paper›PMID 41844523›Full record

ArticleAllergy2026

Involvement of B Cell Subsets in Patients With Steven Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).

Fareed Ahmad, Jericha Miles P Mateo, Febu Elizabeth Joy, Gazala Anamangadan, Seena Manjooran, Anh Jochebeth, Fahad Al-Marri, Sara Al-Khawaga, Amina Al-Obaidli, Ayda AlHammadi and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fareed AhmadDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Jericha Miles P MateoTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Febu Elizabeth JoyDermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Gazala AnamangadanTranslational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Seena ManjooranDermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Anh JochebethDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Fahad Al-MarriDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Sara Al-KhawagaDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Amina Al-ObaidliDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Ayda AlHammadiDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Majid Ali AlamDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
Jörg BuddenkotteDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-2394-3269
Martin SteinhoffDepartment of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-7090-2187

Funding

Hamad Medical Corporation MRC-01-21-736
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B cellsdrug reactionplasmablast B cellsregulatory B cellstriple therapy

Identifiers

PMID41844523
PMCPMC13466171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.